Charlène Martin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Charlène Martin has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Cécile E. Malnou
Infinity – Toulouse Institute for Infectious and Inflammatory Diseases Université de Toulouse, INSERM, CNRS Toulouse France
2 shared publications - Delphine Duchanois
Obstetrics Department, Paule de Viguier Hospital, CHU Toulouse
2 shared publications - Hélène Martin
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université de Toulouse, INSERM, CNRS, UPS, Toulouse, France
2 shared publications - Loïc Guimbaud
INSERM, CNRS, Infinity - Toulouse Institute for Infectious and Inflammatory Diseases, Univ Toulouse
2 shared publications - Paul Guerby
Department of Obstetrics and Gynecology CHU Toulouse Toulouse France
2 shared publications Adrien Thiesson
1 shared publication
Latest Publications
- Open Access
- 31 December 2025
- Published by MyJove Corporation
- No. 226,p. e69525
JoVE Video Dataset
The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.
- 31 December 2025
- Published by MyJove Corporation
- No. 226,p. e69525
Open AccessJoVE Video Dataset
The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.
- Open Access
- 30 December 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 226,p. e69525
Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.
- 30 December 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 226,p. e69525
Open AccessEx vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.